tradingkey.logo

Stereotaxis Inc

STXS

2.800USD

+0.040+1.45%
Cierre 09/18, 16:00ETCotizaciones retrasadas 15 min
240.80MCap. mercado
PérdidaP/E TTM

Stereotaxis Inc

2.800

+0.040+1.45%
Más Datos de Stereotaxis Inc Compañía
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Información de la empresa
Símbolo de cotizaciónSTXS
Nombre de la empresaStereotaxis Inc
Fecha de salida a bolsaAug 12, 2004
Director ejecutivoMr. David Leo Fischel
Número de empleados139
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 12
Dirección710 N Tucker Blvd
CiudadST. LOUIS
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal63101
Teléfono13146786100
Sitio Webhttps://www.stereotaxis.com/
Símbolo de cotizaciónSTXS
Fecha de salida a bolsaAug 12, 2004
Director ejecutivoMr. David Leo Fischel
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.92M
+0.31%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.97K
+9.43%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
345.11K
+14.49%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+42.86%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
138.64K
+45.98%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
89.28K
+95.75%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.92M
+0.31%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.97K
+9.43%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
345.11K
+14.49%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+42.86%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
138.64K
+45.98%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
89.28K
+95.75%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
International
13.49M
50.12%
United States
13.43M
49.88%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 13 de ago
Actualizado: mié., 13 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fischel (Nathan)
15.28%
Dafna Capital Management, LLC
15.02%
Kiani (Joe E)
9.73%
Lagoda Investment Management, L.P.
5.15%
BlackRock Institutional Trust Company, N.A.
3.96%
Otro
50.86%
Accionistas
Accionistas
Proporción
Fischel (Nathan)
15.28%
Dafna Capital Management, LLC
15.02%
Kiani (Joe E)
9.73%
Lagoda Investment Management, L.P.
5.15%
BlackRock Institutional Trust Company, N.A.
3.96%
Otro
50.86%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
29.25%
Hedge Fund
19.28%
Investment Advisor
17.15%
Investment Advisor/Hedge Fund
9.29%
Corporation
3.38%
Research Firm
0.44%
Bank and Trust
0.06%
Insurance Company
0.02%
Pension Fund
0.01%
Otro
21.12%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
2023Q3
189
52.12M
65.60%
-9.17M
2023Q2
205
51.88M
65.54%
-5.57M
2023Q1
209
48.14M
64.14%
-13.36M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fischel (Nathan)
13.88M
16.14%
+13.63M
+5575.52%
Mar 17, 2025
Dafna Capital Management, LLC
13.68M
15.91%
--
--
Mar 31, 2025
Kiani (Joe E)
8.86M
10.3%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.38M
5.09%
+254.31K
+6.16%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.54M
4.11%
-109.40K
-3.00%
Mar 31, 2025
The Vanguard Group, Inc.
3.53M
4.11%
+58.52K
+1.68%
Mar 31, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.58%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.85M
3.32%
+62.79K
+2.25%
Mar 31, 2025
Isaac (Paul J)
2.05M
2.39%
+2.05M
--
Mar 10, 2025
Essex Investment Management Company, LLC
1.56M
1.81%
+343.13K
+28.29%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI